NCT06653478 Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
| NCT ID | NCT06653478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Condition | Artificial Intelligence |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2022-06-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To improve the accuracy of risk prediction, screening and treatment outcome of cancer, we aim to establish a medical database that includes standardized and structured clinical diagnosis and treatment information, image features, pathological features, and multi-omics information and to develop a multi-modal data fusion-based technology system using artificial intelligence technology based on database.
Eligibility Criteria
Inclusion Criteria: 1. Participants with the suspected of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision 2. Participants that have signed informed consent. 3. Participants with detailed electronic medical records, image records, pathological records, multi-omics information, and other important clinical diagnostic information. 4. Healthy participants with no clinical diagnosis of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision. Exclusion Criteria: 1. Participants with primary clinical and pathological data missing. 2. Participants lost to follow-up. 3. Participants with too poor medical image quality to perform segment and mark ROI accurately
Contact & Investigator
Yang Jin
PRINCIPAL INVESTIGATOR
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Frequently Asked Questions
Who can join the NCT06653478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Artificial Intelligence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06653478 currently recruiting?
Yes, NCT06653478 is actively recruiting participants. Contact the research team at whuhjy@126.com for enrollment information.
Where is the NCT06653478 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT06653478 clinical trial?
NCT06653478 is sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. The principal investigator is Yang Jin at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. The trial plans to enroll 3,000 participants.